Skip to main content

A phase 1 first-in-human study evaluating safety, pharmacokinetics, and efficacy of ABBV-969 in adult subjects with metastatic castration-resistant prostate cancer.

Open
  • Protocol code: M24-742
  • EudraCT code: _
  • Service: Unclassified
  • Principal investigator:  Valderrama Rodríguez, Angelica
  • Pathology: Tumors
  • Phase: Fase I